33 results
DEFR14A
RNAZ
TransCode Therapeutics Inc
20 May 24
Revised proxy
4:00pm
and practices we use;
coordinating the oversight and reviewing the adequacy of our internal control over financial reporting and enterprise-wide risk … and Board’s Role in Risk Oversight
Currently, the role of chairperson of the Board is separated from the role of Chief Executive Officer, and we plan to keep
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
;
delays and changes in regulatory requirements, policy and guidelines, including the imposition of additional regulatory oversight around clinical … to the performance of our contract manufacturers. We must depend on our suppliers for proper oversight and control of their operations. Our outside
PRE 14A
0bmer8 yc
31 Mar 23
Preliminary proxy
4:17pm
8-K
dhnh4ojoup7
3 Aug 22
TransCode Therapeutics and MD Anderson Announce Strategic Alliance to Advance RNA Therapies for Oncology
4:05pm
DRS
p551h 6pv68fm4wf69
29 Jul 22
Draft registration statement
12:00am
DEF 14A
h42e9fes3fkuv xkd9
2 May 22
Definitive proxy
4:02pm